Patents by Inventor Cezmi Akdis

Cezmi Akdis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220071554
    Abstract: The present invention relates to a medical device and a method for assessing and monitoring epithelial barrier function in vivo of a subject using electrical impedance measurements. The method comprises initiating an impedance measurement session including passing an electrical current through the skin of the subject to obtain values of skin impedance of a target tissue region, said data comprising at least one impedance value measured in the target tissue region at different tissue layers. Further, an evaluation procedure is applied for analyzing the epithelial barrier function in the target tissue region based on the measured data set of impedance values for the target tissue region at different tissue layers. The procedure evaluates the obtained data set of impedance values to provide an outcome indicating a status of the epithelial barrier function of the subject.
    Type: Application
    Filed: October 17, 2019
    Publication date: March 10, 2022
    Applicant: SCIBASE AB
    Inventors: Simon Grant, Cezmi Akdis, Arturo Rinaldi
  • Patent number: 10960032
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: March 30, 2021
    Assignee: SCHWEIZERISCHES FORSCHUNGSINSTITUT FÜR HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • Publication number: 20200164003
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Application
    Filed: December 3, 2019
    Publication date: May 28, 2020
    Applicant: SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • Patent number: 10537597
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: January 21, 2020
    Assignee: Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • Publication number: 20180296613
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Applicant: SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • Publication number: 20160077089
    Abstract: The present invention relates to methods for the detection of human platelet alloantigens (HPAs) on human platelets, methods for the detection of human antibodies against HPAs, and diagnostic test devices for carrying our said methods.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 17, 2016
    Inventors: Manfred Schawaller, Claudio Rhyner, Cezmi Akdis, Max Wiki, Reto Crameri
  • Publication number: 20150010903
    Abstract: The present invention relates to a method for the detection of a substance in an aqueous, physiological or chemical liquid using the evanescence field method, and to a diagnostic device for carrying out said method.
    Type: Application
    Filed: March 12, 2012
    Publication date: January 8, 2015
    Applicant: DAVOS DIAGNOSTICS AG
    Inventors: Manfred Schawaller, Claudio Rhyner, Cezmi Akdis, Max Wiki, Reto Crameri